金石亚药(300434.SZ)：预计2025年净利润同比增长29.58%～68.31%

Core Viewpoint - Jinshi Yao (300434.SZ) expects a net profit attributable to shareholders of 118.91 million to 154.45 million yuan for 2025, representing a year-on-year growth of 29.58% to 68.31% [1] Group 1: Financial Performance - The company anticipates a net profit of 97.90 million to 133.44 million yuan after deducting non-recurring gains and losses, indicating a year-on-year growth of 18.96% to 62.15% [1] - The overall business remains stable, with profit growth supported by effective budget optimization and cost control measures [1] Group 2: Business Development - The new materials and machinery sectors have benefited from successful commercialization of prior R&D results, leading to improved sales gross margin and gross profit [1] - Increased demand for cold medicine has positively impacted sales of anti-influenza virus products, further enhancing the company's profitability [1] Group 3: Non-recurring Gains - The estimated impact of non-recurring gains and losses on net profit is approximately 21.01 million yuan [1]